Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark Earl Hensley currently holds 343,750 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), valued at approximately $0. This represents their equity stake as Chief Operating Officer.
Based on SEC Form 4 filings, Mark Earl Hensley has been a net neutral trader of HRTX stock. They have purchased $0 and sold $0 worth of shares.
Mark Earl Hensley's most recent insider trade was on Aug 6, 2026, when they sold 31,250 shares at $0.00 per share.
Mark Earl Hensley serves as Chief Operating Officer at HERON THERAPEUTICS, INC. /DE/ (HRTX). They have executed 9 insider transactions totaling $0 over their tenure at the company.
Mark Earl Hensley holds the position of Chief Operating Officer at HERON THERAPEUTICS, INC. /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Mark Earl Hensley has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Mark Earl Hensley was on Aug 6, 2026, when they sold $4.4K worth of HRTX shares. This transaction involved 8,888 shares at $0.50 per share.
Mark Earl Hensley currently owns 343,750 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark Earl Hensley's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark Earl Hensley has 9 Form 4 filings on record as an insider at HERON THERAPEUTICS, INC. /DE/.
Set alerts for Mark Earl Hensley and 40,000+ other insiders.